Who are SSG and Paromomycin sulphate's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): loteprednol etabonate/tobramycin opthalmic suspension, Minocycline HCl Microspheres, Amoxicillin-Clarithromycin-Lansoprazole, Gentamicin + narrow spectrum betalactam, Clindamycin/benzoyl peroxide gel, Duac® fixed dose combination gel.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/ssg-and-paromomycin-sulphate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

SSG and Paromomycin sulphate — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

SSG and Paromomycin sulphate (SSG and Paromomycin sulphate) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Amino-guanidine and aminoglycoside antibiotic. Area: Infectious Diseases.

phase 3 Amino-guanidine and aminoglycoside antibiotic Ribosome Infectious Diseases Small molecule Live · refreshed every 30 min

Target snapshot

SSG and Paromomycin sulphate (SSG and Paromomycin sulphate) — Drugs for Neglected Diseases. SSG and Paromomycin sulphate work by inhibiting protein synthesis in the parasite.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
SSG and Paromomycin sulphate TARGET	SSG and Paromomycin sulphate	Drugs for Neglected Diseases	phase 3	Amino-guanidine and aminoglycoside antibiotic	Ribosome
loteprednol etabonate/tobramycin opthalmic suspension	loteprednol etabonate/tobramycin opthalmic suspension	Bausch & Lomb Incorporated	marketed	Corticosteroid/Aminoglycoside antibiotic combination	Glucocorticoid receptor (loteprednol); bacterial ribosome 30S subunit (tobramycin)
Minocycline HCl Microspheres	Minocycline HCl Microspheres	OraPharma	marketed	Tetracycline antibiotic	Bacterial 30S ribosome
Amoxicillin-Clarithromycin-Lansoprazole	Amoxicillin-Clarithromycin-Lansoprazole	Fatma Zehra Arvas	marketed	Triple therapy antibiotic combination with proton pump inhibitor	Helicobacter pylori bacterial ribosomes (amoxicillin and clarithromycin); H+/K+-ATPase (lansoprazole)
Gentamicin + narrow spectrum betalactam	Gentamicin + narrow spectrum betalactam	University Hospital, Akershus	marketed	Aminoglycoside + Beta-lactam antibiotic combination	Bacterial 30S ribosome (gentamicin); Penicillin-binding proteins (beta-lactam)
Clindamycin/benzoyl peroxide gel	Clindamycin/benzoyl peroxide gel	Actavis Inc.	marketed	Antibiotic/keratolytic combination	Bacterial 50S ribosome (clindamycin); reactive oxygen species generation (benzoyl peroxide)
Duac® fixed dose combination gel	Duac® fixed dose combination gel	GlaxoSmithKline	marketed	Topical antibiotic combination	Bacterial ribosome (clindamycin); reactive oxygen species generation (benzoyl peroxide)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Amino-guanidine and aminoglycoside antibiotic class)

Drugs for Neglected Diseases · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). SSG and Paromomycin sulphate — Competitive Intelligence Brief. https://druglandscape.com/ci/ssg-and-paromomycin-sulphate. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab